THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES
Objective: In inflammatory bowel disease (IBD), there is no reliable biomarker, yet. We aimed to determine whether Serum Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) could be useful as a marker for the diagnosis and/or the determination of disease activity in patients with IBD....
Saved in:
| Main Authors: | Yasin Kutlu, İlkim Deniz Toprak, Yasemin Gökden, Hasan Eruzun, Yücel Arman, Şengül Aydın Yoldemir, Zeki Toprak, Tufan Tükek |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Istanbul University Press
2021-07-01
|
| Series: | İstanbul Tıp Fakültesi Dergisi |
| Subjects: | |
| Online Access: | https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/C7E50A8D2B974D95B69A7139D80ECF57 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies
by: Lianshuai Zhang, et al.
Published: (2025-04-01) -
sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease
by: Davina Biel, et al.
Published: (2023-01-01) -
The utility of sTREM-1 and presepsin to predict infection in pediatric patients receiving mechanical circulatory support
by: Murray Robert, et al.
Published: (2025-06-01) -
Cerebrospinal fluid sTREM2 mediates the associations of α-synuclein with tau pathology in older adults without dementia: two population-based study
by: Yong-Chang Wang, et al.
Published: (2025-07-01) -
The Association Between Serum HMGB2 Levels and Abdominal Aortic Aneurysm in Males: Insights Into the HMGB2–TREM Pathway
by: Liting Pan, et al.
Published: (2025-07-01)